P022 Dilemmas and Debates in Derm
DESCRIPTION
Should Dermatologists present themselves as general medical experts beyond dermatology within traditional and social media? What obligations do dermatologists have to disclose their own or other's diagnostic error to patients? How should dermatologists balance their duties to the best interests of the patient with demands for cost-based decision making? This interactive, case-based, debate-style session will review foundational and contemporary ethical controversies in dermatology using a point-counterpoint format. Attendees will learn practical approaches to addressing ethically challenging scenarios in dermatology. Cases will be drawn from AAD member survey data about ethical issues in dermatology and recent literature.
LEARNING OBJECTIVES
Identify ethical dilemmas that practicing dermatologists in 2024 encounter on a regular basis.
Using ethical frameworks, outline arguments for and against the ways to address these dilemmas.
Demonstrate techniques by which dermatologists can navigate ethical dilemmas in their daily practice.
SCHEDULE
10:30 PM
Introduction
Stephanie Fabbro, MD, FAAD
10:35 PM
Topic 1: Bias and Fairness in AI Algorithms for Skin Disease Diagnoses
Stephanie Fabbro, MD, FAAD, Ivy Lee, MD, FAAD
11:00 PM
Topic 2. Ethical Considerations in Developing and Deploying Dermatological AI Tools
Ivy Lee, MD, FAAD, Stephanie Mengden, MD, FAAD
11:25 PM
Topic 3. Direct-to-Consumer Teledermatology Services
Neal D. Bhatia, MD, FAAD, Mustufa A. Jafry, MD
11:50 PM
Topic 4. The Use of Big Data in Dermatology: Prospects and Privacy Concerns
Anne Louise Housholder, MD, FAAD, Shannon Wongvibulsin, MD, PhD
12:15 AM
Conclusions
Stephanie Fabbro, MD, FAAD
SPEAKERS
Neal D. Bhatia, MD, FAAD
Therapeutics Clinical Research, San Diego, CA
Chen Chen
The Ohio State University
Stephanie Fabbro, MD, FAAD
Rixis Dermatology
Anne Louise Housholder, MD, FAAD
Mustufa A. Jafry, MD
Ivy Lee, MD, FAAD
Stephanie Mengden, MD, FAAD
Shannon Wongvibulsin, MD, PhD
UCLA
HANDOUTS
SPEAKER DISCLOSURES
Neal D. Bhatia, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Aclaris Therapeutics, Inc. – Investigator(Grants/Research Funding); Almirall – Consultant(Honoraria); Alumis – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Biofrontera AG – Consultant(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); Botanix Pharmaceuticals – Consultant (1099 relationship)(Honoraria); Cassiopea S.p.A. – Investigator(Grants/Research Funding); Castle Biosciences – Consultant(Honoraria); Dermeleve – Consultant (1099 relationship)(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria); Johnson and Johnson Consumer Products Company – Investigator(Honoraria); La Roche-Posay Laboratorie Pharmaceutique – Consultant(Honoraria); LEO Pharma, US – Investigator(Grants/Research Funding); Mindera – Investigator(Grants/Research Funding); Nutrafol – Investigator(Grants/Research Funding); Ortho Dermatologics – Consultant(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Practical Dermatology – Other(Honoraria); Sanofi/Regeneron – Consultant(Honoraria), Investigator(Grants/Research Funding); Soligenix, Inc – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Zerigo Health – Investigator(Grants/Research Funding);
Chen Chen
No financial relationships exist with ineligible companies.
Stephanie Fabbro, MD, FAAD
Beiersdorf – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria); Castle Biosciences, Inc – Investigator(Grants/Research Funding); Helsinn Therapeutics – Speaker/Faculty Education(Honoraria); janssen – Advisory Board(Honoraria); Kyowa Kirin – Speaker(Honoraria);
Anne Louise Housholder, MD, FAAD
PatientPoint – Consultant(Honoraria);
Mustufa A. Jafry, MD
No financial relationships exist with ineligible companies.
Ivy Lee, MD, FAAD
DIrect Dermatology – Stockholder(Stock Options);
Stephanie Mengden, MD, FAAD
No financial relationships exist with ineligible companies.
Shannon Wongvibulsin, MD, PhD
Sanofi/Regeneron – Advisory Board(Honoraria); VisualDx – Consultant (1099 relationship)(Honoraria);